42 results about "Menopausal disorders" patented technology

Methods, formulations, and devices for providing transdermal or transmucosal delivery of active agents to subjects in need thereof. The formulations and methods treat symptoms of hormonal disorders including hypogonadism, female sexual desire disorder, female menopausal disorder, and adrenal insufficiency.

It is to provide a pharmaceutical composition which is different from an existing therapeutic agent of an adult disease, of a biochemical reaction-inhibiting type, and which action mechanism is to improve the basal metabolism, wherein the composition has no side effects, and does not generate drug resistance against adult disease; and a method for preventing / treating an adult disease by using the same. It is to provide a composition for preventing / ameliorating an adult disease such as metabolic syndrome, diabetes, hyperlipidemia, hypertension, impaired liver function, renal failure, adiposity, erectile dysfunction, menopausal disorder, shoulder discomfort, and low back pain, comprising 5-aminolevulinic acid (ALA), its derivative, or salt thereof, preferably comprising ALA, its derivative, or salt thereof, and an iron compound such as sodium ferrous citrate, iron sodium citrate and iron ammonium citrate; a food or food material for preventing / ameliorating an adult disease comprising the composition; and a method for using the composition for preparing an agent for preventing / ameliorating an adult disease.

A pharmaceutical composition which is different from an existing therapeutic agent of an adult disease, of a biochemical reaction-inhibiting type, and which action mechanism is to improve the basal metabolism, wherein the composition has no side effects, and does not generate drug resistance against adult disease; and a method for preventing / treating an adult disease by using the same. A composition for preventing / ameliorating an adult disease such as metabolic syndrome, diabetes, hyperlipidemia, hypertension, impaired liver function, renal failure, adiposity, erectile dysfunction, menopausal disorder, shoulder discomfort, and low back pain, comprising 5-aminolevulinic acid (ALA), its derivative, or salt thereof, preferably comprising ALA, its derivative, or salt thereof, and an iron compound such as sodium ferrous citrate, iron sodium citrate and iron ammonium citrate; a food or food material for preventing / ameliorating an adult disease comprising the composition; and a method for using the composition for preparing an agent for preventing / ameliorating an adult disease.

The present invention relates to a composition for improving female climacteric (menopausal) disorder, comprising a combination of a red clover extract and a hops extract as an active ingredient. More specifically, the present invention relates to a food composition for improving female climacteric diseases or a pharmaceutical composition for preventing or treating female climacteric diseases, and a method for preparing the composition for improving female climacteric diseases, wherein the composition comprises the combination of the red clover extract and the hops extract as an active ingredient.

The invention discloses a red yeast linseed meal fermented product and its application, and belongs to the technical field of food processing. A monascus flax meal fermented product is prepared according to the following steps: (1) primary detoxification of the flaxseed meal: controlling the moisture content of the flaxseed meal to 170-200 g / kg, and detoxifying by 800W microwave for 8 minutes; (2) ) Flaxseed meal fermentation and further detoxification: activate Monascus slant for 3 to 4 times, insert into the seed medium, cultivate at 30°C for 3 days, then insert 10% of the inoculum into the fermentation medium, and culture at 30°C 5-7d, after the fermentation is completed, the fermentation broth is concentrated. The invention can not only improve the economic added value of flaxseeds, but also generate huge economic and social benefits.

Novel mercaptophenyl naphthyl methane compounds, their pharmaceutically acceptable salts and compositions comprised thereof are useful for the prevention or treatment of various medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma, cancer of breast, cancer of uterus, cancer of the cervix and cancer of the colon, threatened or habitual abortion, obesity, ovarian development or function, post-partum lactation and depression.